Circulation, Vol 80, 969-982, Copyright © 1989 by American Heart Association
CL Wolfe, ME Moseley, MG Wikstrom, RE Sievers, MF Wendland, JW Dupon, WE Finkbeiner, MJ Lipton, WW Parmley and RC Brasch
To test the hypothesis that contrast-enhanced magnetic resonance imaging
(MRI) and magnetic resonance spectroscopy (MRS) can differentiate
reversible from irreversible myocardial injury, these modalities were used
to study ischemia and reperfusion in a rat model. The presence of ischemia
and reperfusion were confirmed with radiolabeled microspheres (n = 6).
Groups of animals were subjected to either 16 (n = 17), 30 (n = 14), 60 (n
= 11), or 90 (n = 14) minutes of left coronary artery (LCA) occlusion and
60 minutes reperfusion. After albumin-gadolinium (Gd)-DTPA injection,
contrast-enhanced, T1-weighted, spin-echo proton images were acquired at
baseline and every 16 minutes during LCA occlusion and reperfusion. In
separate experiments, 31phosphorus (31P) spectra were acquired at similar
time points during ischemia and reperfusion. After 16 minutes occlusion,
normally perfused myocardium enhanced significantly compared with ischemic
myocardium on MRI (104 +/- 7.9% vs. 61 +/- 11.0%, p less than 0.05, n = 5,
mean +/- SEM, % of baseline value). MRS showed reduced phosphocreatine
(PCr) and adenosine triphosphate (ATP) (58.8 +/- 2.4%, p less than or equal
to 0.01; 81.4 +/- 2.4, p less than or equal to 0.01, n = 12). After 16 or
30 minutes ischemia, reflow resulted in uniform MRI signal intensity of the
ischemic zone compared with normal myocardium (93.5 +/- 11.3 vs. 80.9 +/-
7.0, p = NS, n = 11, % of baseline value at 30 minutes reperfusion) and PCr
recovery on MRS (94.3 +/- 4.0%, p = NS, n = 20, % baseline value at 30
minutes reflow). After 60 and 90 minutes ischemia, reflow resulted in
marked enhancement of reperfused compared with normal myocardium on MRI
(254.0 +/- 30.0 vs. 78.3 +/- 9.2, p less than or equal to 0.01, n = 10) and
no recovery of PCr on MRS (64.1 +/- 3.0, p = NS, n = 14).
Triphenyltetrazolium chloride (TTC) staining revealed transmural myocardial
infarction (MI) in all hearts subjected to 60 or 90 minutes ischemia and
reflow, and small nontransmural MIs in only 2/11 hearts subjected to 16 or
30 minutes ischemia and reperfusion. Thus, 1) MRI with albumin-Gd-DTPA is
useful for identifying myocardial ischemia by enhancing the contrast
between normally perfused and ischemic myocardia; 2) MRI with
albumin-Gd-DTPA is useful for identifying reperfusion after myocardial
ischemia; and 3) after reperfusion, reversible can be distinguished from
irreversible myocardial injury by characteristic findings on MRI and MRS.
ARTICLES
Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy
Department of Internal Medicine (Cardiology), University of California, San Francisco 94143-0124.
This article has been cited by other articles:
![]() |
M. Saeed, O. Weber, R. Lee, L. Do, A. Martin, D. Saloner, P. Ursell, P. Robert, C. Corot, and C. B. Higgins Discrimination of Myocardial Acute and Chronic (Scar) Infarctions on Delayed Contrast Enhanced Magnetic Resonance Imaging With Intravascular Magnetic Resonance Contrast Media J. Am. Coll. Cardiol., November 21, 2006; 48(10): 1961 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Crozier, X. Zhang, J. Wang, J. Cheung, S. R. Kimball, and L. S. Jefferson Activation of signaling pathways and regulatory mechanisms of mRNA translation following myocardial ischemia-reperfusion J Appl Physiol, August 1, 2006; 101(2): 576 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Christman, A. J. Vardanian, Q. Fang, R. E. Sievers, H. H. Fok, and R. J. Lee Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium J. Am. Coll. Cardiol., August 4, 2004; 44(3): 654 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ramani, R. M. Judd, T. A. Holly, T. B. Parrish, V. H. Rigolin, M. A. Parker, C. Callahan, S. W. Fitzgerald, R. O. Bonow, and F. J. Klocke Contrast Magnetic Resonance Imaging in the Assessment of Myocardial Viability in Patients With Stable Coronary Artery Disease and Left Ventricular Dysfunction Circulation, December 15, 1998; 98(24): 2687 - 2694. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bremerich, M. F. Wendland, H.a. Arheden, R. Wyttenbach, D. W. Gao, J. P. Huberty, M. W. Dae, C. B. Higgins, and M. Saeed Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging J. Am. Coll. Cardiol., September 1, 1998; 32(3): 787 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Kim, E.-L. Chen, J. A.C. Lima, and R. M. Judd Myocardial Gd-DTPA Kinetics Determine MRI Contrast Enhancement and Reflect the Extent and Severity of Myocardial Injury After Acute Reperfused Infarction Circulation, December 15, 1996; 94(12): 3318 - 3326. [Abstract] [Full Text] |
||||
![]() |
T. Simor, W.-J. Chu, L. Johnson, A. Safranko, M. Doyle, G. M. Pohost, and G. A. Elgavish In Vivo MRI Visualization of Acute Myocardial Ischemia and Reperfusion in Ferrets by the Persistent Action of the Contrast Agent Gd(BME-DTTA) Circulation, December 15, 1995; 92(12): 3549 - 3559. [Abstract] [Full Text] |
||||
![]() |
E. E. van der Wall, H. W. Vliegen, A. de Roos, and A. V.G. Bruschke Magnetic Resonance Imaging in Coronary Artery Disease Circulation, November 1, 1995; 92(9): 2723 - 2739. [Abstract] [Full Text] |
||||
![]() |
R. M. Judd, C. H. Lugo-Olivieri, M. Arai, T. Kondo, P. Croisille, J. A.C. Lima, V. Mohan, L. C. Becker, and E. A. Zerhouni Physiological Basis of Myocardial Contrast Enhancement in Fast Magnetic Resonance Images of 2-Day-Old Reperfused Canine Infarcts Circulation, October 1, 1995; 92(7): 1902 - 1910. [Abstract] [Full Text] |
||||
![]() |
J. A. C. Lima, R. M. Judd, A. Bazille, S. P. Schulman, E. Atalar, and E. A. Zerhouni Regional Heterogeneity of Human Myocardial Infarcts Demonstrated by Contrast-Enhanced MRI : Potential Mechanisms Circulation, September 1, 1995; 92(5): 1117 - 1125. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |